Clinical Trial Update: Pharmacological Characteristics of Intranasally Given Dexmedetomidine in Paediatric Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining pharmacological characteristics of intranasal dexmedetomidine for procedural sedation in pediatric patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Procedural Sedation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Turku University Hospital | Conditions: Procedural Sedation | Phase 4 | Status: COMPLETED